141 related articles for article (PubMed ID: 30420208)
1. Periostin deletion suppresses late-phase response in mouse experimental allergic conjunctivitis.
Asada Y; Okano M; Ishida W; Iwamoto S; Fukuda K; Hirakata T; Tada N; Fukushima A; Ebihara N; Kudo A; Matsuda A
Allergol Int; 2019 Apr; 68(2):233-239. PubMed ID: 30420208
[TBL] [Abstract][Full Text] [Related]
2. Roles of Epithelial Cell-Derived Type 2-Initiating Cytokines in Experimental Allergic Conjunctivitis.
Asada Y; Nakae S; Ishida W; Hori K; Sugita J; Sudo K; Fukuda K; Fukushima A; Suto H; Murakami A; Saito H; Ebihara N; Matsuda A
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5194-202. PubMed ID: 26244295
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E receptor subtype EP3 in conjunctival epithelium regulates late-phase reaction of experimental allergic conjunctivitis.
Ueta M; Matsuoka T; Narumiya S; Kinoshita S
J Allergy Clin Immunol; 2009 Feb; 123(2):466-71. PubMed ID: 18996575
[TBL] [Abstract][Full Text] [Related]
4. Endogenous IL-17 does not play a significant role in the development of experimental murine allergic conjunctivitis.
Fukushima A; Sumi T; Ishida W; Yamada J; Iwakura Y; Ueno H
Int Arch Allergy Immunol; 2008; 147(3):206-12. PubMed ID: 18594150
[TBL] [Abstract][Full Text] [Related]
5. Endogenous interleukin-10 produced by antigen-irrelevant cells promotes the development of experimental murine allergic conjunctivitis.
Fukushima A; Sumi T; Fukuda K; Kumagai N; Nishida T; Ueno H
Int Arch Allergy Immunol; 2007; 144(1):79-84. PubMed ID: 17505142
[TBL] [Abstract][Full Text] [Related]
6. Contribution of IL-33 to induction and augmentation of experimental allergic conjunctivitis.
Matsuba-Kitamura S; Yoshimoto T; Yasuda K; Futatsugi-Yumikura S; Taki Y; Muto T; Ikeda T; Mimura O; Nakanishi K
Int Immunol; 2010 Jun; 22(6):479-89. PubMed ID: 20501612
[TBL] [Abstract][Full Text] [Related]
7. CD8+ T cells play disparate roles in the induction and the effector phases of murine experimental allergic conjunctivitis.
Fukushima A; Yamaguchi T; Fukuda K; Sumi T; Kumagai N; Nishida T; Imai S; Ueno H
Microbiol Immunol; 2006; 50(9):719-28. PubMed ID: 16985294
[TBL] [Abstract][Full Text] [Related]
8. Role of VLA-4 in the development of allergic conjunctivitis in mice.
Fukushima A; Yamaguchi T; Ishida W; Fukata K; Ueno H
Mol Vis; 2006 Apr; 12():310-7. PubMed ID: 16617298
[TBL] [Abstract][Full Text] [Related]
9. Superoxide dismutase 3 attenuates experimental Th2-driven allergic conjunctivitis.
Lee HJ; Kim BM; Shin S; Kim TY; Chung SH
Clin Immunol; 2017 Mar; 176():49-54. PubMed ID: 28063939
[TBL] [Abstract][Full Text] [Related]
10. Notch ligand Delta-like4 inhibits the development of murine experimental allergic conjunctivitis.
Fukushima A; Sumi T; Ishida W; Ojima A; Kajisako M; Koyanagi A; Koyama N; Yagita H
Immunol Lett; 2008 Dec; 121(2):140-7. PubMed ID: 19027794
[TBL] [Abstract][Full Text] [Related]
11. Participation of CD11b and F4/80 molecules in the conjunctival eosinophilia of experimental allergic conjunctivitis.
Fukushima A; Ishida W; Ojima A; Kajisako M; Sumi T; Yamada J; Tsuru E; Miyazaki J; Tominaga A; Yagita H
Int Arch Allergy Immunol; 2010; 151(2):129-36. PubMed ID: 19752566
[TBL] [Abstract][Full Text] [Related]
12. The immunization protocol determines whether endogenous interferon-gamma suppresses the infiltration of eosinophils into the conjunctiva.
Fukushima A; Yamaguchi T; Ishida W; Fukata K; Ozaki A; Ueno H
Immunol Lett; 2005 Sep; 100(2):189-94. PubMed ID: 15919119
[TBL] [Abstract][Full Text] [Related]
13. Differential modulation of allergic eye disease by chronic and acute ascaris infection.
Schopf L; Luccioli S; Bundoc V; Justice P; Chan CC; Wetzel BJ; Norris HH; Urban JF; Keane-Myers A
Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2772-80. PubMed ID: 16043850
[TBL] [Abstract][Full Text] [Related]
14. Treatment with FTY720 during the induction or effector phase suppresses the development of experimental allergic conjunctivitis in mice.
Sumi T; Fukushima A; Nishino K; Fukuda K; Kumagai N; Nishida T; Ueno H
Cell Biol Int; 2009 Apr; 33(4):534-41. PubMed ID: 19230848
[TBL] [Abstract][Full Text] [Related]
15. The murine CCR3 receptor regulates both eosinophilia and hyperresponsiveness in IgE-mediated allergic conjunctivitis.
Fukuda K; Kuo CH; Morohoshi K; Liu FT; Ono SJ
Br J Ophthalmol; 2012 Aug; 96(8):1132-6. PubMed ID: 22694967
[TBL] [Abstract][Full Text] [Related]
16. Activation of tumour-necrosis factor-related apoptosis-inducing ligand receptor enhances the severity of murine allergic conjunctivitis.
Sumi T; Ishida W; Okumura K; Yagita H; Fukushima A
Br J Ophthalmol; 2009 Jan; 93(1):110-5. PubMed ID: 18782797
[TBL] [Abstract][Full Text] [Related]
17. Experimental Mouse Models of Ragweed- and Papain-Induced Allergic Conjunctivitis.
Matsuda A; Hirakata T; Asada Y; Nakae S
Methods Mol Biol; 2021; 2223():133-149. PubMed ID: 33226592
[TBL] [Abstract][Full Text] [Related]
18. Roles of OX40 in the development of murine experimental allergic conjunctivitis: exacerbation and attenuation by stimulation and blocking of OX40.
Fukushima A; Yamaguchi T; Ishida W; Fukata K; Yagita H; Ueno H
Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):657-63. PubMed ID: 16431965
[TBL] [Abstract][Full Text] [Related]
19. [Establishment of ragweed pollen-specific experimental allergic conjunctivitis mouse model: role of IL-33 in allergic conjunctivitis].
Yoshimoto T
Arerugi; 2011 Jan; 60(1):16-25. PubMed ID: 21346403
[No Abstract] [Full Text] [Related]
20. Oleanolic acid controls allergic and inflammatory responses in experimental allergic conjunctivitis.
Córdova C; Gutiérrez B; Martínez-García C; Martín R; Gallego-Muñoz P; Hernández M; Nieto ML
PLoS One; 2014; 9(4):e91282. PubMed ID: 24699261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
